HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
about
Physiological and functional interactions between Tcf4 and Daxx in colon cancer cellsHMCan: a method for detecting chromatin modifications in cancer samples using ChIP-seq data.The regulation of β-catenin activity and function in cancer: therapeutic opportunitiesHOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.High-level expression of HOXB13 is closely associated with tumor angiogenesis and poor prognosis of hepatocellular carcinomaHOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling.A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer.Cancer associated epigenetic transitions identified by genome-wide histone methylation binding profiles in human colorectal cancer samples and paired normal mucosaDysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer.Epigenetics of prostate cancer: beyond DNA methylationGermline HOXB13 p.Gly84Glu mutation and cancer susceptibility: a pooled analysis of 25 epidemiological studies with 145,257 participates.Overexpression of homeobox B-13 correlates with angiogenesis, aberrant expression of EMT markers, aggressive characteristics and poor prognosis in pancreatic carcinomaHomeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis.Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancersAssociation between germline homeobox B13 (HOXB13) G84E allele and prostate cancer susceptibility: a meta-analysis and trial sequential analysis.The dual roles of homeobox genes in vascularization and wound healing.Oncogenic mechanisms of HOXB13 missense mutations in prostate carcinogenesis.HOXB13 downregulates intracellular zinc and increases NF-κB signaling to promote prostate cancer metastasis.Identification of a link between Wnt/β-catenin signalling and the cell fusion pathway.Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles.Hoxb13 regulatory elements mediate transgene expression during prostate organogenesis and carcinogenesis.Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.Impact of homeobox genes in gastrointestinal cancer.Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq.Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas.Spatio-temporal expression of HOX genes in human hindgut development.HOXB13 expression and promoter methylation as a candidate biomarker in gastric cancer.Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer
P2860
Q24311467-4928DFCB-CDD4-4B49-9100-96152D16327CQ30666001-E4B056FC-F3FE-4232-B1DB-4EBE43A2851CQ33779745-1FD3738A-6DED-4F3B-AFD6-8479595F9C4CQ33818402-BE6E69A1-1B89-40B2-8C82-48B983F2E069Q33898551-9E65A73F-FD8A-4890-A9E6-A41C929AB1E4Q33933887-B6795ADE-8D84-4042-9BC8-16561761EE0BQ33999947-D3B5B0DC-A6E6-415A-A3A7-E7F02FACD94AQ34051772-34438A63-CB2D-426F-9477-A677D6001086Q34147903-50A961A0-B2C6-416C-B108-9972D271858EQ34505232-530FF612-C6D6-4220-92EF-8B5AE9DC1372Q35827235-FD019354-732F-4030-941C-9386C2B7079DQ35919196-A99E4E01-00C6-451C-96B0-A3C0C90B8720Q35973274-3D4E5A32-5E91-42BA-81F2-5DEEC8D89EFEQ37375359-EE17116C-07B8-4EBC-BF68-806207E7B1F7Q37687127-3A43D3EC-B427-42AF-AA08-6A868A91E175Q38053050-8A2B9E77-2062-4A42-AE3B-FAC84F1E782AQ38723089-66DC8CFC-2CDF-49B4-A289-CB5F3C16EB14Q39085739-3D21F89A-1B6E-435B-8B7F-D4B80A1F4CA3Q39438577-62528CF6-72CF-47B0-92F9-68C39874B179Q40950245-7C1568BF-920B-4B6A-BCF3-D6299A26E2D0Q42220559-82ABDEAD-82CA-4D26-B2A0-FAC7FE83E806Q42269072-908D3D94-93A6-47FC-AEA9-8D458E9E4316Q42385858-FF724E1B-14DF-418C-880B-C16AB6C73F0AQ42775899-D2AF9096-9986-42B3-BB52-C40736C448BEQ44843862-EA45D1F8-874B-4EA7-BAB4-80F3BD869953Q50084342-0F038AC1-9FBF-4B62-A642-1C823E425C36Q50779766-B1FF7D6F-5AD1-4DD0-87F9-7248344D4A93Q55347438-D15A00D1-EC7C-4996-9500-EB19A433987FQ57265601-1110DF58-ACF5-4395-95D4-73F81D7E0E59
P2860
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
@ast
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
@en
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
@nl
type
label
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
@ast
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
@en
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
@nl
prefLabel
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
@ast
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
@en
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
@nl
P2093
P2860
P3181
P356
P1476
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
@en
P2093
P J Loehrer
T A Gardner
P2860
P2888
P304
P3181
P356
10.1038/SJ.BJC.6602631
P407
P577
2005-06-20T00:00:00Z
P5875
P6179
1038838800